UCLA Research: Hormone Replacement Therapy & Brain Health

For decades, hormone replacement therapy (HRT) has been widely associated with easing hot flashes, improving sleep, and stabilizing mood during menopause. Now, emerging research suggests its benefits may extend far beyond symptom relief—possibly playing a protective role against brain inflammation and neurodegenerative disease.

A recent study from the University of California, Los Angeles (UCLA) has uncovered a biological pathway linking estrogen loss to brain inflammation, a key contributor to conditions such as Alzheimer’s disease and multiple sclerosis (MS). The findings add new depth to our understanding of why women face a higher lifetime risk of certain neurological disorders and how hormone therapy could help mitigate that risk (UCLA Health).

The Genetic Link Behind Brain Inflammation

At the center of this research is a gene known as KDM6A, located on the X chromosome. This gene plays a role in regulating immune activity in the brain. Because women have two X chromosomes, they also carry two copies of KDM6A—potentially increasing susceptibility to inflammation-related neurological conditions.

Researchers found that when KDM6A activity becomes dysregulated, it may trigger excessive immune responses in the brain, contributing to chronic inflammation. Over time, this inflammatory environment can damage neurons and disrupt communication between brain cells, laying the groundwork for diseases such as Alzheimer’s and MS (Nature Neuroscience).

Why Estrogen Matters More Than We Thought

Estrogen is increasingly recognized as a powerful anti-inflammatory hormone. Beyond its role in reproductive health, it helps regulate immune responses, supports blood flow to the brain, and protects neurons from oxidative stress.

During menopause, estrogen levels decline sharply. According to researchers, this hormonal shift may remove a key layer of protection against brain inflammation—especially in women already genetically predisposed due to the KDM6A gene (Journal of Neuroinflammation).

This connection helps explain why women are disproportionately affected by Alzheimer’s disease and why symptoms such as brain fog, memory lapses, and mood changes often appear during midlife.

What the UCLA Study Found

In the UCLA study, scientists deactivated the KDM6A gene in laboratory mice that had developed an MS-like neurological condition. Remarkably, the animals showed noticeable improvement in disease severity and inflammation levels.

While animal studies do not directly translate to humans, the results strongly suggest that controlling inflammation—especially during hormonal transitions—could be a key strategy for preventing or slowing neurological disease progression (UCLA Health).

Researchers emphasize that estrogen appears to counteract inflammatory pathways influenced by KDM6A, highlighting hormone replacement therapy as a potential preventive tool rather than just a symptom treatment.

Hormone Replacement Therapy: More Than Symptom Relief

Medical experts say this research reinforces a growing shift in how HRT is viewed.

“There’s clear bone protection, some cardiovascular benefit, and now emerging evidence of possible long-term neurological protection,” explained Dr. Shelly Holmstrom, an OB-GYN with Advent Health.

Hormone replacement therapy works by restoring estrogen levels under medical supervision, compensating for what the body naturally loses during menopause. According to clinicians, many women notice improvements not only in hot flashes and sleep quality but also in cognitive clarity, mood stability, and joint health (North American Menopause Society).

Improved Sleep and Reduced Dementia Risk

Sleep disruption is a common but often underestimated symptom of menopause. Research has consistently linked poor sleep in midlife to a higher risk of cognitive decline and Alzheimer’s disease later on (Alzheimer’s & Dementia Journal).

By improving sleep quality, hormone therapy may offer an indirect but meaningful layer of brain protection. Better sleep supports memory consolidation, clears metabolic waste from the brain, and reduces inflammatory markers.

“A lack of quality sleep affects everything—from mood and focus to long-term brain resilience,” Dr. Holmstrom noted.

A Patient’s Perspective

For many women, the benefits of HRT are tangible and life-changing.

Tracy Middleton, a hormone therapy patient, described struggling with insomnia, irregular cycles, and hot flashes during early menopause. After starting HRT, she noticed significant improvement across multiple symptoms.

“I’m sleeping better, my energy is back, and I feel more mentally clear,” she shared. “What excites me most is knowing this may also protect my brain in the long run.”

Her experience echoes what clinicians increasingly hear from patients who receive personalized, well-monitored hormone therapy.

A Personalized Medical Decision

Experts caution that hormone replacement therapy is not a one-size-fits-all solution. Individual risk factors—such as personal and family medical history—must be carefully evaluated.

“Education is key,” said Saad Alam, CEO and co-founder of Hone Health. “Women should work with qualified medical providers to understand what’s happening in their bodies and whether hormone levels are contributing to their symptoms.”

The Bigger Picture

This research underscores a broader shift in medicine: recognizing menopause as a neurological and systemic transition—not just a reproductive milestone. As scientists continue uncovering the links between hormones, genetics, and brain health, hormone replacement therapy may emerge as a critical tool in preventive neuroscience for women.

References

1. Appelbaum, Lior, et al. “Sex Differences in Neuroinflammation and the Role of Estrogen.” Journal of Neuroinflammation, vol. 20, no. 1, 2023.

2. Cirelli, Chiara. “Sleep, Brain Repair, and Neurodegeneration.” Alzheimer’s & Dementia, 2022.

3. North American Menopause Society. Hormone Therapy Position Statement. NAMS, 2023.

4. UCLA Health. “New Research Links Estrogen Loss to Brain Inflammation.” UCLA Health Newsroom, 2024.

5. Voskuhl, Rhonda. “Sex Differences in Multiple Sclerosis Biology.” Nature Neuroscience, vol. 25, 2022.